Conditions: Seasonal Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 40
Healthy volunteers: no

Brief summary:
We hypothesize that those patients with purely seasonal allergic rhinitis will decongest better than those subjects with another cause contributing to their symptoms. These latter patients will not improve as well on an intranasal steroid as those who decongest well, potentially explaining the 60% response rate in prior studies.

Detailed description:

Arms:
arm 1: 2 weeks of treatment arm 2: 2 weeks of treatment

Interventions: intervention 1: mometasone furoate nasal spray intervention 2: placebo
Intervention descriptions: intervention 1: 2 puffs in each nostril once a day for 2 weeks intervention 2: 2 puffs in each nostril once a day for 2 weeks

Protocol document: